Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Cox

Showing results (231-240 of 235) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 235 results.
Journal of Medical Genetics|September 7, 2016
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSMelissa C Southey, David E Goldgar, Robert Winqvist, et al.
Nature|October 24, 2017
Association analysis identifies 65 new breast cancer risk lociKyriaki Michailidou, Sara Lindström, Joe Dennis, et al.
Gynecologic Oncology|May 6, 2015
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer, Antoinette Hollestelle, Frederieke H van der Baan, et al.
Nature Genetics|March 29, 2013
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancerStig E Bojesen, Karen A Pooley, Sharon E Johnatty, et al.
Nature Genetics|October 24, 2017
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancerRoger L Milne, Karoline B Kuchenbaecker, Kyriaki Michailidou, et al.
Pageof 24

Showing results (231-240 of 235) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 235 results.
Journal of Medical Genetics|September 7, 2016
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSMelissa C Southey, David E Goldgar, Robert Winqvist, et al.
Nature|October 24, 2017
Association analysis identifies 65 new breast cancer risk lociKyriaki Michailidou, Sara Lindström, Joe Dennis, et al.
Gynecologic Oncology|May 6, 2015
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer, Antoinette Hollestelle, Frederieke H van der Baan, et al.
Nature Genetics|March 29, 2013
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancerStig E Bojesen, Karen A Pooley, Sharon E Johnatty, et al.
Nature Genetics|October 24, 2017
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancerRoger L Milne, Karoline B Kuchenbaecker, Kyriaki Michailidou, et al.
Pageof 24